Challenge of managing sickle cell disease in a pediatric population living in kinshasa, democratic republic of congo: A sickle cell center experience

Hemoglobin

Volumn 38, Issue 3, 2014, Pages 196-200

  Aloni, Michel Ntetani ^a   Nkee, Leonard ^b  

^a UNIVERSITY OF KINSHASA   (Congo)

^b School of Medicine University Simon Kimbangu   (Democratic Republic Congo)

Author keywords

Antibioprophylaxis; Children; Democratic republic of congo (DRC); Immunization; Kinshasa; Management; Sickle cell disease

Indexed keywords

HEPATITIS B VACCINE; HYDROXYUREA; PNEUMOCOCCUS VACCINE; ANTISICKLING AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL FEATURE; CONGO; FEMALE; HAEMOPHILUS INFLUENZAE; HEALTH INSURANCE; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; NEWBORN PERIOD; PREVALENCE; SALMONELLA; SICKLE CELL; SICKLE CELL ANEMIA; ANEMIA, SICKLE CELL; BLOODBORNE BACTERIUM; CONTROLLED STUDY; DEMOCRATIC REPUBLIC CONGO; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CHILD; CHILD, PRESCHOOL; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; HUMANS; HYDROXYUREA; IMMUNIZATION; MALE; RETROSPECTIVE STUDIES;

EID: 84900479752     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2014.896810     Document Type: Article

References (43)

1. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 2010;376(9757):2018-2031.
2. Malowany JI, Butany J. Pathology of sickle cell disease. Semin Diagn Pathol. 2012;29(1):49-55.
3. Taylor SM, Messina JP, Hand CC, et al. Molecular malaria epidemiology: Mapping and burden estimates for the Democratic Republic of the Congo, 2007. PLoS One. 2011;6(1):e16420.
4. Vandepitte J, Motulsky AG. Abnormal haemoglobins in the Kasai province of the Belgian Congo. Nature. 1956;177(4512):757.
5. Agasa B, Bosunga K, Opara A, et al. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: What impact on transfusion policy? Transfus Med. 2010; 20(1):62-65.
6. Omanga U, Muganga N, Kapepela M. Bacterial septicemias in children with homozygous sickle cell anemia. Analysis of 69 cases. Ann Pediatr (Paris). 1989;36(5):315-318.
7. Aloni MN, Tshimanga BK, Ekulu PM, et al. Malaria, clinical features and acute crisis in children suffering from sickle cell disease in resource-limited settings: A retrospective description of 90 cases. Pathog Glob Health. 2013;107(4):198-201.
8. Tshilolo L, Summa V, Gregorj C, et al. Foetal haemoglobin, erythrocytes containing foetal haemoglobin, and hematological features in Congolese patients with sickle cell anaemia. Anemia. 2012;2012:105349.
9. Tshilolo LM, Mukendi RK, Wembonyama SO. Blood transfusion rate in Congolese patients with sickle cell anemia. Indian J Pediatr. 2007;74(8):735-738.
10. Le? PQ, Ferster A, Cotton F, et al. Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management. Med Trop (Mars). 2010;70(5-6):467-470.
11. Howard J, Davies SC. Sickle cell disease in North Europe. Scand J Clin Lab Invest. 2007;67(1):27-38.
12. De Montalembert M, Tshilolo L. Is therapeutic progress in the management of sickle cell disease applicable in sub-Saharan Africa? Med Trop (Mars). 2007;67(6):612-616.
13. Makani J, Williams TN, Marsh K. Sickle cell disease in Africa: Burden and research priorities. Ann Trop Med Parasitol. 2007; 101(1):3-14.
14. Grosse SD, Odame I, Atrash HK, et al. Sickle cell disease in Africa: A neglected cause of early childhood mortality. Am J Prev Med. 2011;41(6 Suppl 4):398-405.
15. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood. 2004;103(11):4023-4027.
16. Telfer P, Coen P, Chakravorty S, et al. Clinical outcomes in children with sickle cell disease living in England: A neonatal cohort in East London. Haematologica. 2007;92(7):905-912.
17. Tshilolo L, Aissi LM, Lukusa D, et al. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: Experience from a pioneer project on 31 204 newborns. J Clin Pathol. 2009; 62(1):35-38.
18. Diagne I, Ndiaye O, Moreira C, et al. Sickle cell disease in children in Dakar, Senegal. Arch Pediatr. 2000;7(1):16-24.
19. Ayéroué J, Kafando E, Kam L, et al. Hemoglobin sickle cell disease: Experience of the Yalgado Ouedraogo University Hospital of Ouagadougou, Burkina Faso. Arch Pediatr. 2009;16(4):316-321.
20. Brown BJ, Akinkunmi BF, Fatunde OJ. Age at diagnosis of sickle cell disease in a developing country. Afr J Med Med Sci. 2010; 39(3):221-225.
21. Ndiaye FS, Nanho Danho C, Sekongon YM, et al. Anemic complications of sickle cell disease: Frequency and evolution of 338 cases reported at Yopougon Teaching Hospital. Dakar Med. 2008;53(2):99-104.
22. Kamble M, Chatruvedi P. Epidemiology of sickle cell disease in a rural hospital of central India. Indian Pediatr. 2000; 37(4):391-396.
23. Inati A, Jradi O, Tarabay H, et al. Sickle cell disease: The Lebanese experience. Int J Lab Hematol. 2007;29(6):399-408.
24. Yé D, Kouéta F, Dao L, et al. Pediatric management of sickle cell disease: Experience at the Charles de Gaulle University Children?s Hospital in Ouagadougou (Burkina Faso). Sante. 2008; 18(2):71-75.
25. Makani J, Cox SE, Soka D, et al. Mortality in sickle cell anemia in Africa: A prospective cohort study in Tanzania. PLoS One. 2011; 16(2):14699.
26. Odame I. Developing a global agenda for sickle cell disease: Report of an international symposium and workshop in Cotonou, Republic of Benin. Am J Prev Med. 2010;38(4 Suppl):571-575.
27. Diop S, Thiam D, Cisse M, et al. New results in clinical severity of homozygous sickle cell anemia, in Dakar, Senegal. Hematol Cell Ther. 1999;41(5):217-221.
28. Tshilolo L, Mukendi R, Girot R. Sickle cell anemia in the south of Zaire. Study of two series of 251 and 340 patients followed-up 1988-1992. Arch Pediatr. 1996;3(2):104-111.
29. Bain BJ. Neonatal/newborn haemoglobinopathy screening in Europe and Africa. J Clin Pathol. 2009;62(1):53-56.
30. Thuilliez V, Ditsambou V, Mba JR, et al. Current aspects of sickle cell disease in children in Gabon. Arch Pediatr. 1996; 3(7):668-674.
31. Wonkam A, Ponde C, Nicholson N, et al. The burden of sickle cell disease in Cape Town. S Afr Med J. 2012;102(9):752-754.
32. De Montalembert M. Management of sickle cell disease. Rev Prat. 2004;54(14):1557-1564 (French).
33. Mabiala-Babela JR, Nkanza-Kaluwako SA, Ganga-Zandzou PS, et al. Effects of age on causes of hospitalization in children suffering from sickle cell disease. Bull Soc Pathol Exot. 2005; 98(3):392-393.
34. Fosdal MB, Wojner-Alexandrov AW. Events of hospitalization among children with sickle cell disease. J Pediatr Nurs. 2007; 22(4):342-346.
35. Sangho H, Keïta HD, Keïta AS, et al. Management of sickle cells disease by households in Bamako. Mali Med. 2009;24(3):53-56.
36. Diagne I, Diagne-Gueye ND, Signate-Sy H, et al. Management of children with sickle cell disease in Africa: Experience in a cohort of children at the Royal Albert Hospital in Dakar. Med Trop (Mars). 2003;63(4-5):513-520.
37. Athale UH, Chintu C. Clinical analysis of mortality in hospitalized Zambian children with sickle cell anaemia. East Afr Med J. 1994; 71(6):388-391.
38. Hardie R, King L, Fraser R, Reid M. Prevalence of pneumococcal polysaccharide vaccine administration and incidence of invasive pneumococcal disease in children in Jamaica aged over 4 years with sickle cell disease diagnosed by newborn screening. Ann Trop Paediatr. 2009;29(3):197-202.
39. Nacoulma EW, Kam L, Gue EE, et al. Vaccination status of children with sickle cell disease in Ouagadougou (Burkina Faso). Sante. 2006;16(3):155-160.
40. Adamkiewicz TV, Silk BJ, Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics. 2008; 121(3):562-569.
41. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44(11):1428-1433.
42. Kizito ME, Mworozi E, Ndugwa C, Serjeant GR. Bacteraemia in homozygous sickle cell disease in Africa: Is pneumococcal prophylaxis justified? Arch Dis Child. 2007;92(1):21-23.
43. Muyembe-Tamfum JJ, Veyi J, Kaswa M, et al. An outbreak of peritonitis caused by multidrug-resistant Salmonella Typhi in Kinshasa, Democratic Republic of Congo. Travel Med Infect Dis. 2009;7(1):40-43.